Position in KRYS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$349,092,534
+$51,227,101 QoQ
Shares Held
939,254
-18.5% QoQ
Ownership
3.17%
of shares outstanding
% of Portfolio
12.03%
of 13F equity value
Holder Rank
#7
of 416 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. KRYS ranks #1 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
This page
|
939,254 | $349,092,534 | |
| 2 | CELC |
Celcuity Inc.
|
1,704,318 | $178,305,749 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
2,927,895 | $160,858,551 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
1,843,504 | $72,117,876 | |
| 5 | VCEL |
Vericel Corp
|
1,459,152 | $64,917,672 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
177,517 | $59,430,916 | |
| 7 | GERN |
Geron Corp
|
42,808,659 | $54,795,083 | |
| 8 | ERAS |
Erasca, Inc.
|
2,700,000 | $49,464,000 |
All Filings in KRYS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $349,092,534 | 939,254 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $297,865,433 | 1,153,087 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $232,008,685 | 941,059 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $179,854,236 | 1,018,831 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $126,869,806 | 922,958 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $79,648,967 | 441,758 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $56,143,654 | 358,379 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,496,687 | 216,979 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,138,640 | 126,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,963,913 | 84,100 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,962,400 | 40,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,675,472 | 117,892 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,936,540 | 110,192 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,819,430 | 85,179 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,910,550 | 188,217 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,451,040 | 207,332 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,082,888 | 214,482 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,252,483 | 289,337 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $15,979,168 | 228,437 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,553,869 | 125,529 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,591,972 | 67,529 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,853,661 | 166,844 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $625,380 | 10,423 | Shares | Sole | 2021-04-29 | |
| No filing history on record for this holder in this stock. | ||||||